Biomarkers In Cancer Targeted Immunotherapy
15 mars 2022 03h53 HE
|
KuicK Research
Delhi, March 15, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022
10 mars 2022 07h30 HE
|
Cognition Therapeutics, Inc.
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage neuroscience company developing drugs that treat age-related degenerative diseases of the...
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results
17 févr. 2022 17h43 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
04 janv. 2022 08h33 HE
|
Inotiv, Inc.
-- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- Expected to enhance scale, broaden customer base...
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
16 nov. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
C3i Center Inc. Secures CAP Accreditation, Launches New Lab Spinoff
09 nov. 2021 10h00 HE
|
Centre C3i Inc.
MONTRÉAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the cell...
Fluidigm Announces Third Quarter 2021 Financial Results
08 nov. 2021 16h02 HE
|
Fluidigm Corporation
Board Undertaking Review of Range of Value-Enhancing Opportunities SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
20 oct. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
02 sept. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
09 août 2021 11h14 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...